Get all premium features to the best stock analysis tool

Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform

New U.S. intellectual property protections expand use of Minovia's leading technology in mitochondrial-based therapies for primary mitochondrial and severe renal diseases New U.S. intellectual property protections expand use of Minovia's leading technology in mitochondrial-based therapies for primary mitochondrial and severe renal diseases